Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX4211 in Type 2 Diabetes Mellitus
NCT00962065Phase 2Completed
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Aug 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sotagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Lexicon Pharmaceuticals, Inc.. Started Aug 2009; status: completed.
02
Drugs
sotagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00962065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00962065.